Business Context and Reporting Period
This Form 8-K Current Report from Harvard Bioscience, Inc. (HBIO) covers events occurring on May 18, 2021, specifically the Company's 2021 Annual Meeting of Stockholders. The filing details corporate governance actions, including the election of directors, ratification of auditors, and approval of executive compensation plans.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes and Voting Results
The filing reports the following material outcomes from the Annual Meeting:
- Election of Directors: Alan Edrick was elected as a Class III Director for a three-year term ending in 2024. He received 28,081,962 votes for, with 2,127,078 votes withheld.
- Auditor Ratification: Stockholders ratified the appointment of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021. The vote was 34,560,445 for, 15,078 against, and 1,758 abstained.
- 2021 Incentive Plan: The Harvard Bioscience, Inc. 2021 Incentive Plan was approved. The vote was 29,374,490 for, 814,653 against, and 19,897 abstained.
- Executive Compensation: The compensation of named executive officers was approved via a non-binding advisory vote. The vote was 29,916,663 for, 261,382 against, and 30,995 abstained.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, future outlook, or specific risk factors. It references the definitive proxy statement filed on April 8, 2021, for a detailed description of the 2021 Incentive Plan, which is incorporated by reference.
Investor Verification Checklist
- Verify the full text of the 2021 Incentive Plan (Exhibit 10.1) to understand the specific terms, share limits, and vesting schedules.
- Review the definitive proxy statement filed on April 8, 2021, for comprehensive details on the proposals and management's rationale.
- Confirm the tenure and background of the newly elected director, Alan Edrick.
- Note that Grant Thornton LLP is the confirmed auditor for the fiscal year ending December 31, 2021.